ADIENNE Pharma & Biotech SA
Records under this name other than the patents ADIENNE Pharma & Biotech SA holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 12 patents it holds.
Showing 1 to 2 of 2 · Back to ADIENNE Pharma & Biotech SA
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,976,151 | Artificial DNA sequence with optimized leader function in 5′(5′-UTR) for the over-expression of recombinant proteins in plants and method for the production of recombinant proteins in plants Lapsed on the fee record Ended May 22, 2026 · From the USPTO record | Lapsed on the fee record | Ended May 22, 2026 | From the USPTO record |
| US 9,085,775 | Artificial DNA sequence with optimized leader function in 5′ (5′-UTR) for the improved expression of heterologous proteins in plants Lapsed on the fee record Ended Jul 21, 2023 · From the USPTO record | Lapsed on the fee record | Ended Jul 21, 2023 | From the USPTO record |